|
GlaxoSmithKline Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
52624.29 Cr.
|
P/BV
|
21.01
|
Book Value (Rs.)
|
147.85
|
|
52 Week High/Low (Rs.)
|
3121/2088
|
FV/ML
|
10/1
|
P/E(X)
|
50.80
|
|
Bookclosure
|
29/05/2026
|
EPS (Rs.)
|
61.15
|
Div Yield (%)
|
1.83
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 1385.39 | 1255.19 | 959.80 | 841.49 | 2475.65 |
| | | | | | |
| Net CashFlow From Operating Activities | 903.30 | 1289.90 | 582.02 | 484.23 | 810.75 |
| Net Cash Used In Investing Activities | 396.98 | -45.80 | 8.71 | 807.85 | -405.51 |
| Net Cash Used From Financing Activities | -737.08 | -769.42 | -561.50 | -1543.32 | -524.24 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 563.20 | 474.68 | 29.23 | -251.25 | -119.00 |
| Cash And Cash Equivalents Begin of Year | 538.85 | 64.17 | 34.94 | 286.19 | 405.19 |
| Cash And Cash Equivalents End Of Year | 1102.05 | 538.85 | 64.17 | 34.94 | 286.19 |